Dashboard
Manage Tickers

ACN Accenture plc

NYSE accenture.com


$ 241.82 $ 0.00 (0 %)    

Tuesday, 14-Oct-2025 07:39:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 595.70 $ 0.00 (0 %)
DIA $ 458.07 $ 0.00 (0 %)
SPY $ 657.76 $ 0.00 (0 %)
TLT $ 90.95 $ 0.00 (0 %)
GLD $ 379.74 $ 0.00 (0 %)
$ 243.56
$ 242.23
$ 240.28 x 1
$ 241.60 x 74
-- - --
$ 227.92 - $ 391.86
3,572,509
na
160.38B
$ 1.07
$ 20.89
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-10-2025 08-31-2025 10-K
2 06-20-2025 05-31-2025 10-Q
3 03-20-2025 02-28-2025 10-Q
4 12-19-2024 11-30-2024 10-Q
5 10-10-2024 08-31-2024 10-K
6 06-20-2024 05-31-2024 10-Q
7 03-21-2024 02-29-2024 10-Q
8 12-19-2023 11-30-2023 10-Q
9 10-12-2023 08-31-2023 10-K
10 06-22-2023 05-31-2023 10-Q
11 03-23-2023 02-28-2023 10-Q
12 12-16-2022 11-30-2022 10-Q
13 10-12-2022 08-31-2022 10-K
14 06-23-2022 05-31-2022 10-Q
15 03-17-2022 02-28-2022 10-Q
16 12-16-2021 11-30-2021 10-Q
17 10-15-2021 08-31-2021 10-K
18 06-24-2021 05-31-2021 10-Q
19 03-18-2021 02-28-2021 10-Q
20 12-17-2020 11-30-2020 10-Q
21 10-22-2020 08-31-2020 10-K
22 06-25-2020 05-31-2020 10-Q
23 03-19-2020 02-29-2020 10-Q
24 12-19-2019 11-30-2019 10-Q
25 10-29-2019 08-31-2019 10-K
26 06-27-2019 05-31-2019 10-Q
27 03-28-2019 02-28-2019 10-Q
28 12-20-2018 11-30-2018 10-Q
29 10-24-2018 08-31-2018 10-K
30 06-28-2018 05-31-2018 10-Q
31 03-22-2018 02-28-2018 10-Q
32 12-21-2017 11-30-2017 10-Q
33 10-26-2017 08-31-2017 10-K
34 06-22-2017 05-31-2017 10-Q
35 03-23-2017 02-28-2017 10-Q
36 12-21-2016 11-30-2016 10-Q
37 10-28-2016 08-31-2016 10-K
38 06-23-2016 05-31-2016 10-Q
39 03-24-2016 02-29-2016 10-Q
40 12-17-2015 11-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

accenture-acquires-decho-to-expand-palantir-and-gen-ai-capabilities-across-health-and-public-service-clients-deal-terms-not-disclosed
Accenture Acquires Decho To Expand Palanti...
10/14/2025 09:51:57

Core News & Articles
Rep. Rick Allen Has Sold Up to $15K Worth ...
10/08/2025 15:00:34

check-out-what-whales-are-doing-with-acn
Check Out What Whales Are Doing With ACN
10/06/2025 19:02:45

wolfspeed-rockets-in-momentum-rankings-while-costco-and-accenture-strengthen-fundamentals
Wolfspeed Rockets In Momentum Rankings Whi...
10/03/2025 19:57:18

This week, Benzinga's proprietary Growth, Value, Quality and Momentum data revealed major swings among several popular stoc...

telenor-taps-infosys-for-hr-makeover-on-oracle-cloud
Telenor Taps Infosys For HR Makeover On Or...
10/03/2025 12:04:52

Infosys partners with Telenor Shared Services to deploy Oracle Cloud HCM, aiming to streamline HR operations and more.

how-is-the-market-feeling-about-accenture-plc
How Is The Market Feeling About Accenture ...
10/01/2025 13:01:05

accenture-to-acquire-aidemy-after-successful-tender-offer-will-integrate-130-professionals-into-ai-and-reskilling-services-terms-not-disclosed
Accenture To Acquire Aidemy After Successf...
09/30/2025 05:33:27

Core News & Articles
Bipartisan Pair Of U.S. Senators Reintrodu...
09/29/2025 20:57:24

- Reuters

mizuho-maintains-outperform-on-accenture-lowers-price-target-to-309
Mizuho Maintains Outperform on Accenture, ...
09/29/2025 16:00:58

Mizuho analyst Dan Dolev maintains Accenture (NYSE: ACN) with a Outperform and lowers the price target from $348 to $309.

accenture-invests-in-uk-startup-rehuman-to-bring-ai-powered-customer-engagement-to-insurance-industry
Accenture Invests In UK Startup Rehuman To...
09/29/2025 12:00:19

Accenture (NYSE: ACN) has invested in Rehuman, a UK-based insurtech startup that is aim

consumer-tech-news-sep-22--sep-26-us-gdp-rebound-shutdown-threat-ai-push-by-big-tech-and-corporate-earnings-beats
Consumer Tech News (Sep. 22 – Sep. 26): US...
09/28/2025 11:31:26

The U.S. economy grew at a 3.8% annual rate in the second quarter, its fastest pace since the third quarter of 2023 and above t...

bmo-capital-maintains-market-perform-on-accenture-lowers-price-target-to-270
BMO Capital Maintains Market Perform on Ac...
09/26/2025 17:45:16

BMO Capital analyst Keith Bachman maintains Accenture (NYSE: ACN) with a Market Perform and lowers the price target from $32...

goldman-sachs-maintains-buy-on-accenture-lowers-price-target-to-330
Goldman Sachs Maintains Buy on Accenture, ...
09/26/2025 17:04:19

Goldman Sachs analyst James Schneider maintains Accenture (NYSE: ACN) with a Buy and lowers the price target from $370 to $3...

evercore-isi-group-maintains-outperform-on-accenture-lowers-price-target-to-280
Evercore ISI Group Maintains Outperform on...
09/26/2025 16:19:07

Evercore ISI Group analyst David Togut maintains Accenture (NYSE: ACN) with a Outperform and lowers the price target from $3...

these-analysts-slash-their-forecasts-on-accenture-after-q4-results
These Analysts Slash Their Forecasts On Ac...
09/26/2025 15:18:12

Accenture plc (NYSE: ACN) posted better-than-expected fourth-quarter 2025 results on Thursday.

accenture-posts-solid-growth--can-restructuring-and-ai-push-secure-long-term-profitability
Accenture Posts Solid Growth — Can Restruc...
09/26/2025 15:14:03

Accenture (NYSE: ACN) reported fourth-quarter revenue of $17.6 billion, topping expectations, with bookings rising 3% to $21.3 ...

1000-invested-in-accenture-20-years-ago-would-be-worth-this-much-today
$1000 Invested In Accenture 20 Years Ago W...
09/26/2025 15:00:39

Accenture (NYSE: ACN) has outperformed the market over the past 20 years by 3.01% on an annualized basis producing an average a...

td-cowen-maintains-buy-on-accenture-lowers-price-target-to-295
TD Cowen Maintains Buy on Accenture, Lower...
09/26/2025 14:35:03

TD Cowen analyst Bryan Bergin maintains Accenture (NYSE: ACN) with a Buy and lowers the price target from $313 to $295.

rbc-capital-maintains-outperform-on-accenture-lowers-price-target-to-285
RBC Capital Maintains Outperform on Accent...
09/26/2025 14:06:25

RBC Capital analyst Daniel R. Perlin maintains Accenture (NYSE: ACN) with a Outperform and lowers the price target from $372...

17-analysts-assess-accenture-what-you-need-to-know
17 Analysts Assess Accenture: What You Nee...
09/26/2025 14:00:47

In the preceding three months, 17 analysts have released ratings for Accenture (NYSE: ACN), presenting a wide array of perspect...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION